Companies:
50,763
Total Market Cap:
150894007677180.62
Global Rank
#48619
Country Rank
#125
Market Cap
1.05 M
Price
0.0209
Change (%)
3.26%
Volume
787,595
Oxurion NV's latest marketcap:
1.05 M
As of 10/04/2025, Oxurion NV's market capitalization has reached $1.05 M. According to our data, Oxurion NV is the 48619th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 1.05 M |
| Revenue (ttm) | 2,348.2 |
| Net Income (ttm) | 2.3 M |
| Shares Out | 50.38 M |
| EPS (ttm) | 0.73 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 09/05/2025 |
Market Cap Chart
Data Updated: 10/04/2025
Oxurion NV's yearly market capitalization.
Oxurion NV has seen its market value drop from €236.75 M to €896,720 since 2014, representing a total decrease of 99.62% and an annual compound decline rate (CAGR) of 40.44%.
| Date | Market Cap(€) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 10/04/2025 | €896,720 | $1.05 M | 30.2% | 48619 |
| 12/31/2024 | €766,134 | $793,117.24 | -73.79% | 44573 |
| 12/29/2023 | €2.92 M | $3.23 M | -62.57% | 40784 |
| 12/30/2022 | €7.81 M | $8.36 M | -88.99% | 36599 |
| 12/31/2021 | €70.93 M | $80.62 M | -27.49% | 24517 |
| 12/31/2020 | €97.83 M | $119.49 M | -13.39% | 19598 |
| 12/31/2019 | €112.96 M | $126.66 M | -18.47% | 16915 |
| 12/31/2018 | €138.54 M | $158.85 M | 13.47% | 15029 |
| 12/29/2017 | €122.09 M | $146.44 M | 33.77% | 16073 |
| 12/30/2016 | €91.27 M | $95.98 M | -29.75% | 16122 |
Company Profile
About Oxurion NV
Oxurion NV is a biopharmaceutical company dedicated to developing innovative treatments to prevent blindness and preserve vision.
Focus Areas
- Specializes in ophthalmic therapies for retinal disorders
- Targets conditions such as geographic atrophy and age-related macular degeneration
Company Background
- Founded in 1991
- Headquartered in Leuven, Belgium
- Formerly known as ThromboGenics NV before rebranding to Oxurion NV in September 2018
Frequently Asked Questions
-
What is Oxurion NV's (EBR-OXUR) current market cap?As of 10/04/2025, Oxurion NV (including the parent company, if applicable) has an estimated market capitalization of $1.05 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Oxurion NV (EBR-OXUR) rank globally by market cap?Oxurion NV global market capitalization ranking is approximately 48619 as of 10/04/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.